tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Cash flow

Compare
88 Followers

Barinthus Biotherapeutics Cash Flow

BRNS's free cash flow for Q3 2024 was $-11.43M. For the 2024 fiscal year, BRNS's free cash flow was decreased by $-35.77M and operating cash flow was $-13.88M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -50.92M$ -14.43M$ -32.58M$ -11.03M$ -18.76M
Investing Cash Flow
$ -5.41M$ -5.75M$ -12.91M$ -293.00K$ 1.93M
Financing Cash Flow
$ 1.87M$ 325.00K$ 222.74M$ 41.44M-
End Cash Position
$ 142.09M$ 194.38M$ 214.05M$ 43.27M$ 11.43M
Free Cash Flow
$ -56.34M$ -20.57M$ -33.73M$ -11.32M$ -18.89M
Currency in USD

Barinthus Biotherapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis